A Deep Dive into Section 3(k) Analysis of Ericsson’s Eight Patents – Ericsson vs. Lava – Part VII

The Delhi High Court analysed the validity of eight Ericsson patents under Section 3(k), following Lava’s challenge. Except for the first patent, the Court upheld the remaining patents, finding them to involve technical advancements beyond mere algorithms or mathematical methods.

Read more about A Deep Dive into Section 3(k) Analysis of Ericsson’s Eight Patents – Ericsson vs. Lava – Part VII

Revocation of Patent on the ground of misrepresentation – Ericsson vs Lava : Part VI

The Delhi High Court in Ericsson vs Lava clarified that revocation of a patent on the ground of misrepresentation requires strong, clear evidence of intentional deceit. In this case, Lava failed to meet the legal threshold, resulting in rejection of its revocation claim.

Read more about Revocation of Patent on the ground of misrepresentation – Ericsson vs Lava : Part VI

PSITA is not omniscient, says Madras High Court. Overturns refusal order in favour of Microsoft.

The Madras High Court has overturned the refusal of Microsoft’s patent application, clarifying the correct approach to assessing inventive step and the PSITA standard under Indian law. The decision highlights the need for a nuanced analysis of prior art and patent claims.

Read more about PSITA is not omniscient, says Madras High Court. Overturns refusal order in favour of Microsoft.

Nokia Vs. Oppo: Standard Essential Patents and Deposit during Suit Pendency

The Delhi High Court addressed Nokia’s request for interim royalty deposit from Oppo in a standard essential patents dispute. The judgment clarifies the application of FRAND licensing and the legal standards governing SEP litigation in India.

Read more about Nokia Vs. Oppo: Standard Essential Patents and Deposit during Suit Pendency

CASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.

The Delhi High Court’s decision in Novo Nordisk AS vs. Union of India addresses key procedural and substantive aspects of post grant patent opposition in India. The judgment clarifies evidentiary requirements, parties’ rights regarding Opposition Board reports, and the strict timelines under the Patents Act and Rules.

Read more about CASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.